Literature DB >> 22974079

The evolution and value of bleeding assessment tools.

Natalia Rydz1, Paula D James.   

Abstract

A personal history of excessive mucocutaneous bleeding is a key component in the diagnosis of a number of mild bleeding disorders, including von Willebrand disease (VWD), platelet function disorders (PFD), and coagulation factor deficiencies. However, the evaluation of hemorrhagic symptoms is a well-recognized challenge for both patients and physicians, because the reporting and interpretation of bleeding symptoms is subjective. As a result, bleeding assessment tools (BATs) have been developed and studied in a variety of clinical settings. This work has been pioneered by a group of Italian researchers, and the resultant 'Vicenza Bleeding Questionnaire' stands as the original BAT. In this review, we will discuss the modifications of the Vicenza Bleeding Questionnaire that have taken place over the years, as well as the validation studies that have been published. Other BATs that have been developed and published will be reviewed, as will the special situations of assessing pediatric bleeding as well as menorrhagia. Lastly, the clinical utility of BATs will be discussed including remaining challenges and future directions for the field.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  bleeding scores; bruising; epistaxis; menorrhagia; mucocutaneous bleeding; platelet function disorder; von Willebrand disease

Mesh:

Year:  2012        PMID: 22974079      PMCID: PMC3893309          DOI: 10.1111/j.1538-7836.2012.04923.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  35 in total

1.  von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia.

Authors:  A Dilley; C Drews; C Miller; C Lally; H Austin; D Ramaswamy; D Lurye; B Evatt
Journal:  Obstet Gynecol       Date:  2001-04       Impact factor: 7.661

2.  Menorrhagia.

Authors:  M Rees
Journal:  Br Med J (Clin Res Ed)       Date:  1987-03-21

Review 3.  Von Willebrand disease type 1: a diagnosis in search of a disease.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2002-10-31       Impact factor: 22.113

4.  von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.

Authors:  J A Dean; V S Blanchette; M D Carcao; A M Stain; C R Sparling; J Siekmann; P L Turecek; D Lillicrap; M L Rand
Journal:  Thromb Haemost       Date:  2000-09       Impact factor: 5.249

Review 5.  Clinical diagnosis of von Willebrand disease.

Authors:  A B Federici
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

6.  Platelet functional defects in women with unexplained menorrhagia.

Authors:  C S Philipp; A Dilley; C H Miller; B Evatt; A Baranwal; R Schwartz; G Bachmann; P Saidi
Journal:  J Thromb Haemost       Date:  2003-03       Impact factor: 5.824

7.  Reliability and reproducibility of classification of children as "bleeders" versus "non-bleeders" using a questionnaire for significant mucocutaneous bleeding.

Authors:  Iris Hedlund-Treutiger; Shoshana Revel-Vilk; Victor S Blanchette; Julie A Curtin; David Lillicrap; Margaret L Rand
Journal:  J Pediatr Hematol Oncol       Date:  2004-08       Impact factor: 1.289

8.  Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States.

Authors:  A Kirtava; S Crudder; A Dilley; C Lally; B Evatt
Journal:  Haemophilia       Date:  2004-03       Impact factor: 4.287

9.  Bleeding risks associated with inheritance of the Quebec platelet disorder.

Authors:  Heather McKay; Francine Derome; M Anwar Haq; Susan Whittaker; Emmy Arnold; Frédéric Adam; Nancy M Heddle; Georges E Rivard; Catherine P M Hayward
Journal:  Blood       Date:  2004-03-16       Impact factor: 22.113

10.  Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice.

Authors:  C Bidlingmaier; V Grote; U Budde; M Olivieri; K Kurnik
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

View more
  33 in total

1.  Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States.

Authors:  Veronica H Flood; Pamela A Christopherson; Joan Cox Gill; Kenneth D Friedman; Sandra L Haberichter; Daniel B Bellissimo; Rupa A Udani; Mahua Dasgupta; Raymond G Hoffmann; Margaret V Ragni; Amy D Shapiro; Jeanne M Lusher; Steven R Lentz; Thomas C Abshire; Cindy Leissinger; W Keith Hoots; Marilyn J Manco-Johnson; Ralph A Gruppo; Lisa N Boggio; Kate T Montgomery; Anne C Goodeve; Paula D James; David Lillicrap; Ian R Peake; Robert R Montgomery
Journal:  Blood       Date:  2016-02-09       Impact factor: 22.113

Review 2.  Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.

Authors:  Sarah H O'Brien
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

4.  A 24-year-old woman with heavy menstrual bleeding.

Authors:  Michelle Sholzberg; Jerome Teitel; Lisa K Hicks
Journal:  CMAJ       Date:  2017-06-05       Impact factor: 8.262

5.  Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels.

Authors:  Michelle Lavin; Sonia Aguila; Sonja Schneppenheim; Niall Dalton; Kenneth L Jones; Jamie M O'Sullivan; Niamh M O'Connell; Kevin Ryan; Barry White; Mary Byrne; Marie Rafferty; Mairead M Doyle; Margaret Nolan; Roger J S Preston; Ulrich Budde; Paula James; Jorge Di Paola; James S O'Donnell
Journal:  Blood       Date:  2017-09-15       Impact factor: 22.113

Review 6.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

7.  Perioperative management of patients with von Willebrand disease.

Authors:  James S O'Donnell; Michelle Lavin
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

8.  The clinical management of factor XI deficiency in pregnant women.

Authors:  Allison P Wheeler; Celeste Hemingway; David Gailani
Journal:  Expert Rev Hematol       Date:  2020-06-12       Impact factor: 2.929

Review 9.  Molecular testing for disorders of hemostasis.

Authors:  D Lillicrap
Journal:  Int J Lab Hematol       Date:  2013-06       Impact factor: 2.877

10.  Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system.

Authors:  Yuto Nakajima; Keiji Nogami; Koji Yada; Takeshi Kawamura; Kenichi Ogiwara; Shoko Furukawa; Naruto Shimonishi; Masahiro Takeyama; Midori Shima
Journal:  Int J Hematol       Date:  2019-11-18       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.